Antonio Caruz

Dr. Antonio Caruz

Universidad de Jaén. Departamento de Biología Experimental; Campus de Las Lagunillas, s/n; 23071 Jaén, Spain
orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 1997 in Journal of Hepatology
Verified
Journal Article
Closed access
BSBasilio Soto
Basilio Soto
ASArmandó Sánchez-Quijano
Armandó Sánchez-Quijano
Luis RodrigoLuis Rodrigo
Luis Rodrigo
JOJuan Angel del Olmo
Juan Angel del Olmo
MGManuel García-Bengoechea
Manuel García-Bengoechea
ELEduardo Lissen
Eduardo Lissen

1 December 2000 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
TPTanya Ponomaryov
Tanya Ponomaryov
APAmnon Peled
Amnon Peled
IPIsabelle Petit
Isabelle Petit
RTRussell Taichman
Russell Taichman
LHLiliana Habler
Liliana Habler
TLTsvee Lapidot
Tsvee Lapidot
The chemokine stromal-derived factor-1 (SDF-1) controls many aspects of stem cell function. Details of its regulation and sites of production are currently unknown. We report that in the bone marrow, SDF-1 is produced mainly by immature osteoblasts and endothelial cells. Conditioning with DNA-damaging agents (ionizing irradiation, cyclophosphamide, and 5-fluorouracil) caused an increase in SDF-1 expression and in CXCR4-dependent homing and repopulation by human stem cells transplanted into NOD/SCID mice. Our findings suggest that immature osteoblasts and endothelial cells control stem cell homing, retention, and repopulation by secreting SDF-1, which also participates in host defense responses to DNA damage.

1 November 1999 in The American Journal of Pathology
Verified
Journal Article
Closed access
JPJosé Luis Pablos
José Luis Pablos
AAAli Amara
Ali Amara
ABAnne Bouloc
Anne Bouloc
BSBegoña Santiago
Begoña Santiago
Antonio CaruzAntonio Caruz
Antonio Caruz
FAFernando Arenzana-Seisdedos
Fernando Arenzana-Seisdedos

1 October 2010 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
JPJuan A. Pineda
Juan A. Pineda
Antonio CaruzAntonio Caruz
Antonio Caruz
Antonio Rivero-JuarezAntonio Rivero-Juarez
Antonio Rivero-Juarez
KNKarin Neukam
Karin Neukam
ISIrene Salas
Irene Salas
JMJuan Macías
Juan Macías
Background. Variation in the IL28B gene is associated with sustained virologic response (SVR) to pegylated interferon plus ribavirin in hepatitis C v

17 April 1998 in FEBS Letters
Verified
Journal Article
Closed access
Antonio CaruzAntonio Caruz
Antonio Caruz
MSM. Samsom
M. Samsom
JAJ.M. Alonso
J.M. Alonso
JAJosé Alcami
José Alcami
FBF. Baleux
F. Baleux
FAF. Arenzana-Seisdedos
F. Arenzana-Seisdedos

15 January 2012 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
Manuela SironiManuela Sironi
Manuela Sironi
Mara BiasinMara Biasin
Mara Biasin
RCRachele Cagliani
Rachele Cagliani
Diego ForniDiego Forni
Diego Forni
MLMariacristina De Luca
Mariacristina De Luca
mario clericimario clerici
mario clerici
TLR3 recognizes dsRNA and activates antiviral immune responses through the production of inflammatory cytokines and type I IFNs. Genetic association studies have provided evidence concerning the role of a polymorphism in TLR3 (rs3775291, Leu412Phe) in viral infection susceptibility. We genotyped rs3775291 in a population of Spanish HIV-1–exposed seronegative (HESN) individuals who remain HIV seronegative despite repeated exposure through i.v. injection drug use (IDU-HESN individuals) as witnessed by their hepatitis C virus seropositivity. The frequency of individuals carrying at least one 412Phe allele was significantly higher in IDU-HESN individuals compared with that of a matched control sample (odds ratio for a dominant model = 1.87; 95% confidence interval, 1.06–3.34; p = 0.023). To replicate this finding, we analyzed a cohort of Italian, sexually HESN individuals. Similar results were obtained: the frequency of individuals carrying at least one 412Phe allele was significantly higher compared with that of a matched control sample (odds ratio, 1.79; 95% confidence interval, 1.05–3.08; p = 0.029). In vitro infection assays showed that in PBMCs carrying the 412Phe allele, HIV-1Ba-L replication was significantly reduced (p = 0.025) compared with that of Leu/Leu homozygous samples and was associated with a higher expression of factors suggestive of a state of immune activation (IL-6, CCL3, CD69). Similarly, stimulation of PBMCs with a TLR3 agonist indicated that the presence of the 412Phe allele results in a significantly increased expression of CD69 and higher production of proinflammatory cytokines including IL-6 and CCL3. The data of this study indicate that a common TLR3 allele confers immunologically mediated protection from HIV-1 and suggest the potential use of TLR3 triggering in HIV-1 immunotherapy.